Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Pain | 36 | 2024 | 80 | 8.880 |
Why?
|
| Dysmenorrhea | 23 | 2023 | 49 | 7.260 |
Why?
|
| Chronic Pain | 20 | 2024 | 145 | 5.900 |
Why?
|
| Cystitis, Interstitial | 12 | 2024 | 53 | 4.590 |
Why?
|
| Endometriosis | 7 | 2022 | 58 | 3.280 |
Why?
|
| Pain Measurement | 18 | 2024 | 321 | 2.390 |
Why?
|
| Pain Threshold | 12 | 2024 | 58 | 2.360 |
Why?
|
| Urinary Bladder | 7 | 2023 | 246 | 2.240 |
Why?
|
| Laparoscopy | 14 | 2022 | 754 | 2.220 |
Why?
|
| Dyspareunia | 4 | 2022 | 19 | 1.750 |
Why?
|
| Pelvic Floor | 6 | 2022 | 84 | 1.450 |
Why?
|
| Irritable Bowel Syndrome | 5 | 2023 | 45 | 1.350 |
Why?
|
| Visceral Pain | 2 | 2018 | 6 | 1.260 |
Why?
|
| Musculoskeletal Diseases | 5 | 2011 | 34 | 1.260 |
Why?
|
| Female | 63 | 2024 | 44532 | 1.160 |
Why?
|
| Hyperalgesia | 2 | 2017 | 16 | 1.080 |
Why?
|
| Gynecologic Surgical Procedures | 4 | 2021 | 135 | 1.060 |
Why?
|
| Physical Examination | 4 | 2015 | 149 | 0.960 |
Why?
|
| Pelvis | 2 | 2021 | 95 | 0.950 |
Why?
|
| Uterus | 5 | 2018 | 215 | 0.900 |
Why?
|
| Cross-Sectional Studies | 16 | 2023 | 1621 | 0.900 |
Why?
|
| Uterine Myomectomy | 3 | 2017 | 8 | 0.890 |
Why?
|
| Humans | 67 | 2024 | 86643 | 0.830 |
Why?
|
| Gastroenterologists | 1 | 2022 | 30 | 0.800 |
Why?
|
| Hysterectomy | 4 | 2022 | 146 | 0.770 |
Why?
|
| Dysuria | 1 | 2019 | 8 | 0.730 |
Why?
|
| Hemostasis, Surgical | 2 | 2017 | 26 | 0.720 |
Why?
|
| Simulation Training | 1 | 2021 | 88 | 0.720 |
Why?
|
| Constipation | 1 | 2019 | 63 | 0.690 |
Why?
|
| Young Adult | 16 | 2022 | 5976 | 0.680 |
Why?
|
| Adult | 32 | 2023 | 25648 | 0.680 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 56 | 0.670 |
Why?
|
| Prostatitis | 3 | 2024 | 13 | 0.630 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2017 | 17 | 0.610 |
Why?
|
| Uterine Contraction | 1 | 2017 | 9 | 0.610 |
Why?
|
| Platelet Activating Factor | 1 | 2017 | 53 | 0.600 |
Why?
|
| Episiotomy | 1 | 2016 | 2 | 0.590 |
Why?
|
| Uterine Diseases | 1 | 2016 | 19 | 0.590 |
Why?
|
| Vagina | 2 | 2008 | 161 | 0.570 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 115 | 0.570 |
Why?
|
| Nociceptive Pain | 1 | 2015 | 3 | 0.540 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2017 | 18 | 0.530 |
Why?
|
| Chronic Disease | 7 | 2022 | 971 | 0.490 |
Why?
|
| Parity | 1 | 2014 | 93 | 0.480 |
Why?
|
| Motor Cortex | 1 | 2016 | 195 | 0.470 |
Why?
|
| Ultrasonography | 2 | 2013 | 695 | 0.440 |
Why?
|
| Naproxen | 3 | 2021 | 13 | 0.430 |
Why?
|
| Hypoxia | 1 | 2017 | 641 | 0.420 |
Why?
|
| Neuralgia | 1 | 2011 | 28 | 0.400 |
Why?
|
| Analgesia | 1 | 2011 | 57 | 0.380 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 21 | 0.370 |
Why?
|
| Prospective Studies | 6 | 2023 | 4213 | 0.370 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2009 | 14 | 0.360 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 243 | 0.350 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 166 | 0.350 |
Why?
|
| Hysteroscopy | 1 | 2008 | 6 | 0.340 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 115 | 0.340 |
Why?
|
| Adolescent | 8 | 2022 | 8981 | 0.330 |
Why?
|
| Case-Control Studies | 5 | 2019 | 1805 | 0.320 |
Why?
|
| Miniaturization | 1 | 2007 | 13 | 0.320 |
Why?
|
| Oxytocin | 2 | 2020 | 71 | 0.320 |
Why?
|
| Laparoscopes | 1 | 2007 | 15 | 0.310 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 84 | 0.300 |
Why?
|
| Ambulatory Care | 1 | 2008 | 181 | 0.300 |
Why?
|
| Comorbidity | 2 | 2022 | 943 | 0.300 |
Why?
|
| Vasopressins | 2 | 2017 | 49 | 0.290 |
Why?
|
| Pressure | 3 | 2017 | 165 | 0.290 |
Why?
|
| Gynecology | 3 | 2019 | 124 | 0.290 |
Why?
|
| Middle Aged | 15 | 2019 | 25028 | 0.280 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1801 | 0.270 |
Why?
|
| Analgesics | 3 | 2020 | 119 | 0.270 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 74 | 0.260 |
Why?
|
| Benchmarking | 1 | 2005 | 78 | 0.260 |
Why?
|
| Peritoneal Diseases | 1 | 2005 | 15 | 0.260 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 1991 | 0.260 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2705 | 0.260 |
Why?
|
| Abdominal Pain | 1 | 2006 | 137 | 0.250 |
Why?
|
| Tissue Adhesions | 1 | 2005 | 50 | 0.250 |
Why?
|
| Surveys and Questionnaires | 7 | 2020 | 2501 | 0.250 |
Why?
|
| Pain | 3 | 2022 | 391 | 0.240 |
Why?
|
| Depression | 2 | 2018 | 473 | 0.230 |
Why?
|
| Pilot Projects | 5 | 2020 | 839 | 0.220 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 999 | 0.220 |
Why?
|
| Consensus | 2 | 2021 | 335 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 582 | 0.200 |
Why?
|
| Self Report | 2 | 2014 | 288 | 0.200 |
Why?
|
| Syndrome | 3 | 2024 | 446 | 0.190 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 364 | 0.180 |
Why?
|
| Varicose Veins | 1 | 2019 | 10 | 0.170 |
Why?
|
| Vulva | 1 | 2019 | 23 | 0.170 |
Why?
|
| Urination | 1 | 2019 | 37 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 865 | 0.170 |
Why?
|
| Collagenases | 1 | 1998 | 39 | 0.160 |
Why?
|
| Pain, Referred | 1 | 2018 | 2 | 0.160 |
Why?
|
| Lower Extremity | 1 | 2019 | 84 | 0.160 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 19 | 0.160 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2018 | 4 | 0.160 |
Why?
|
| Muscle Cramp | 1 | 2018 | 5 | 0.160 |
Why?
|
| Obstetric Labor, Premature | 1 | 1998 | 58 | 0.160 |
Why?
|
| Dinoprost | 1 | 2017 | 26 | 0.150 |
Why?
|
| Phenotype | 3 | 2022 | 2378 | 0.150 |
Why?
|
| Leiomyoma | 3 | 2017 | 191 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2019 | 376 | 0.150 |
Why?
|
| Pregnancy | 3 | 2014 | 2894 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2018 | 283 | 0.150 |
Why?
|
| Uterine Neoplasms | 3 | 2017 | 227 | 0.150 |
Why?
|
| Diuresis | 1 | 2017 | 29 | 0.150 |
Why?
|
| Perineum | 1 | 2016 | 35 | 0.150 |
Why?
|
| Perfusion | 1 | 2017 | 203 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2017 | 256 | 0.140 |
Why?
|
| Time Factors | 3 | 2014 | 5210 | 0.140 |
Why?
|
| Heart Rate | 1 | 2019 | 492 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 307 | 0.140 |
Why?
|
| Illinois | 2 | 2009 | 462 | 0.140 |
Why?
|
| Risk Factors | 4 | 2023 | 5417 | 0.140 |
Why?
|
| Hemostatics | 1 | 2016 | 56 | 0.140 |
Why?
|
| Anxiety | 1 | 2018 | 287 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 112 | 0.140 |
Why?
|
| Palpation | 1 | 2015 | 18 | 0.140 |
Why?
|
| Pain Management | 1 | 2016 | 127 | 0.130 |
Why?
|
| Symptom Assessment | 1 | 2015 | 65 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2009 | 814 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 596 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2016 | 217 | 0.130 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 185 | 0.130 |
Why?
|
| Pelvic Floor Disorders | 1 | 2015 | 55 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 237 | 0.130 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 240 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1036 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1686 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 594 | 0.120 |
Why?
|
| Australia | 1 | 2014 | 99 | 0.120 |
Why?
|
| Neural Pathways | 1 | 2016 | 308 | 0.120 |
Why?
|
| Fertility | 1 | 2014 | 115 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2019 | 1143 | 0.110 |
Why?
|
| Prevalence | 2 | 2008 | 1239 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1924 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2016 | 548 | 0.110 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1673 | 0.110 |
Why?
|
| Nerve Net | 1 | 2016 | 366 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 859 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2011 | 31 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2011 | 153 | 0.100 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 87 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1019 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 26582 | 0.090 |
Why?
|
| Child | 1 | 2022 | 6927 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 369 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2010 | 92 | 0.090 |
Why?
|
| Surgicenters | 1 | 2008 | 5 | 0.090 |
Why?
|
| Male | 6 | 2024 | 40965 | 0.090 |
Why?
|
| Vulvar Vestibulitis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 663 | 0.080 |
Why?
|
| Internet | 1 | 2010 | 312 | 0.080 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 62 | 0.080 |
Why?
|
| Quality of Life | 3 | 2022 | 1585 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1565 | 0.070 |
Why?
|
| Healthcare Common Procedure Coding System | 1 | 2005 | 1 | 0.070 |
Why?
|
| Brain | 1 | 2016 | 2216 | 0.070 |
Why?
|
| Mice | 3 | 2017 | 11352 | 0.070 |
Why?
|
| North Carolina | 1 | 2005 | 50 | 0.060 |
Why?
|
| United States | 2 | 2008 | 6672 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 364 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2010 | 8489 | 0.060 |
Why?
|
| Obstetrics | 1 | 2005 | 120 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3362 | 0.060 |
Why?
|
| Adoptive Transfer | 2 | 2001 | 168 | 0.060 |
Why?
|
| Thymus Gland | 2 | 2001 | 195 | 0.050 |
Why?
|
| Myalgia | 1 | 2022 | 7 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2005 | 397 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 18415 | 0.050 |
Why?
|
| Goals | 1 | 2022 | 67 | 0.050 |
Why?
|
| Isoantigens | 1 | 2001 | 66 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1169 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 203 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 197 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 40 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2008 | 2207 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 78 | 0.040 |
Why?
|
| Menstruation | 1 | 2018 | 30 | 0.040 |
Why?
|
| Pain Perception | 1 | 2018 | 18 | 0.040 |
Why?
|
| Clonal Deletion | 1 | 1997 | 23 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 1997 | 71 | 0.040 |
Why?
|
| Electromyography | 1 | 2018 | 183 | 0.040 |
Why?
|
| Parasympatholytics | 1 | 2017 | 18 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2017 | 10 | 0.040 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 22 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 1997 | 30 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 28 | 0.040 |
Why?
|
| Denervation | 1 | 2017 | 34 | 0.040 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 29 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2013 | 751 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 1997 | 84 | 0.040 |
Why?
|
| Ablation Techniques | 1 | 2017 | 34 | 0.040 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 41 | 0.040 |
Why?
|
| Ketorolac | 1 | 2016 | 6 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 103 | 0.040 |
Why?
|
| Epitopes | 1 | 1997 | 255 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 2017 | 54 | 0.040 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2016 | 25 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 152 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 223 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 159 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 203 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2016 | 54 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1823 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 2767 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2005 | 1004 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 129 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2016 | 126 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 705 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 326 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2001 | 1065 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 1195 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 327 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 1997 | 265 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2015 | 280 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 413 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 3679 | 0.020 |
Why?
|
| Search Engine | 1 | 2010 | 9 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 103 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2001 | 1047 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2261 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2010 | 572 | 0.020 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2005 | 3 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6509 | 0.020 |
Why?
|
| Pain, Intractable | 1 | 2004 | 11 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7993 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 3092 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 249 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2001 | 130 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 996 | 0.010 |
Why?
|
| Injections, Intralymphatic | 1 | 1997 | 1 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 102 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 100 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 370 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1997 | 172 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 430 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1997 | 337 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 425 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 728 | 0.010 |
Why?
|
| Graft Survival | 1 | 1997 | 884 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 559 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 1540 | 0.010 |
Why?
|